Glucosamine and Blindness unilateral - a phase IV clinical study of FDA data

Summary:

Blindness unilateral is reported as a side effect among people who take Glucosamine (glucosamine), especially for people who are male, 60+ old, also take Nevanac, and have Acromegaly.

The phase IV clinical study analyzes which people have Blindness unilateral when taking Glucosamine. It is created by eHealthMe based on reports of 14,902 people who have side effects when taking Glucosamine from the FDA, and is updated regularly.

What is Glucosamine?

Glucosamine has active ingredients of glucosamine. It is often used in joint pain. eHealthMe is studying from 15,547 Glucosamine users. Check the latest studies of Glucosamine.

What is Blindness unilateral?

Blindness unilateral is found to be associated with 878 drugs and 979 conditions by eHealthMe. Check the latest studies of Blindness unilateral.

On Jul, 13, 2026

14,902 people reported to have side effects when taking Glucosamine.
Among them, 18 people (0.12%) have Blindness unilateral.

Could Glucosamine cause Blindness unilateral?

Among these 18 people:

What is the gender of people who have Blindness unilateral when taking Glucosamine? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Blindness unilateral when taking Glucosamine? *

What are other drugs people take besides Glucosamine? *

What are other side effects people have besides Blindness unilateral? *

Ocular Hyperaemia (an abnormally large amount of blood in eye): 8 people, 44.44%
Weakness: 7 people, 38.89%
High Blood Pressure: 7 people, 38.89%
Abdominal Pain: 7 people, 38.89%
Articular Disc Disorder: 7 people, 38.89%
Blood Growth Hormone Increased: 7 people, 38.89%
Blood Pressure Systolic Increased: 7 people, 38.89%
Body Temperature Decreased: 7 people, 38.89%
Gallbladder Enlargement: 7 people, 38.89%
Gallstones (stone formation by bile component): 7 people, 38.89%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 7 people, 38.89%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 11.11%
Dry Eyes (lack of adequate tears): 2 people, 11.11%
Skin Infection: 1 person, 5.56%
Neuropathy Peripheral (surface nerve damage): 1 person, 5.56%
Neuralgia (pain in one or more nerves): 1 person, 5.56%
Muscle Spasms (muscle contraction): 1 person, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%
High Blood Pressure: 1 person, 5.56%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Glucosamine and have Blindness unilateral?

- Check whether Blindness unilateral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucosamine:

Glucosamine (15,547 reports)

Browse all side effects of Glucosamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness unilateral:

Blindness unilateral (878 drugs)

Browse all the conditions that are associated with Blindness unilateral:

Blindness unilateral (979 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glucosamine (the active ingredients of Glucosamine) and Glucosamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.